TCL Archive In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT March 1, 1996
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014